Eveline A Heijnsdijk

Eveline A M Heijnsdijk

UNVERIFIED PROFILE

Are you Eveline A M Heijnsdijk?   Register this Author

Register author
Eveline A Heijnsdijk

Eveline A M Heijnsdijk

Publications by authors named "Eveline A M Heijnsdijk"

47Publications

1098Reads

46Profile Views

1PubMed Central Citations

All-cause mortality versus cancer-specific mortality as outcome in cancer screening trials: A review and modeling study.

Cancer Med 2019 Oct 18;8(13):6127-6138. Epub 2019 Aug 18.

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cam4.2476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6792501PMC
October 2019

The Impact of Design and Performance in Prostate-Specific Antigen Screening: Differences Between ERSPC Centers.

Eur Urol 2019 Sep 26;76(3):276-279. Epub 2019 Apr 26.

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eururo.2019.04.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800079PMC
September 2019

Informed decision-making based on a leaflet in the context of prostate cancer screening.

Patient Educ Couns 2019 08 13;102(8):1483-1489. Epub 2019 Apr 13.

Department of Public Health, Erasmus MC, University Medical Center Rotterdam, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2019.03.009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6800081PMC
August 2019

Evaluating Parameter Uncertainty in a Simulation Model of Cancer Using Emulators.

Med Decis Making 2019 05 10;39(4):405-413. Epub 2019 Jun 10.

Department of Public Health, Erasmus Medical Center, Rotterdam, Zuid-Holland, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0272989X19837631DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684257PMC
May 2019

Cost-effectiveness of surveillance schedules in older adults with non-muscle-invasive bladder cancer.

BJU Int 2019 02 27;123(2):307-312. Epub 2018 Aug 27.

Departments of Urology, Epidemiology and Health Policy and Management, UNC Lineberger Comprehensive Cancer Center, Chapel Hill, NC, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.14502DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6378589PMC
February 2019

Summary statement on screening for prostate cancer in Europe.

Int J Cancer 2018 02 25;142(4):741-746. Epub 2017 Oct 25.

Department of Public Health, Erasmus Medical Center, Wytemaweg 80, CN Rotterdam, 3015, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.31102DOI Listing
February 2018

Comparative effectiveness of prostate cancer screening between the ages of 55 and 69 years followed by active surveillance.

Cancer 2018 02 12;124(3):507-513. Epub 2017 Dec 12.

Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.31141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6680244PMC
February 2018

Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.

Ann Intern Med 2017 Oct 5;167(7):449-455. Epub 2017 Sep 5.

From University of Michigan, Ann Arbor, Michigan; Fred Hutchinson Cancer Research Center, Seattle, Washington; Erasmus Medical Center, Rotterdam, the Netherlands; National Cancer Institute, Bethesda, Maryland; Queen Mary University of London, London, United Kingdom; Sahlgrenska University Hospital, Göteborg, Sweden; Johns Hopkins Medicine, Baltimore, Maryland; University of Tampere, Tampere, Finland; Washington University School of Medicine, St. Louis, Missouri; University of Colorado, Denver, Colorado; Provinciaal Instituut voor Hygiëne, Antwerp, Belgium; Kantonsspital Aarau, Aarau, Switzerland; Institute for Cancer Prevention, Florence, Italy; Universidad Complutense de Madrid, Parla, Madrid, Spain; and Université de Lille, Lille, France.

View Article

Download full-text PDF

Source
http://annals.org/article.aspx?doi=10.7326/M16-2586
Publisher Site
http://dx.doi.org/10.7326/M16-2586DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5734053PMC
October 2017

When should active surveillance for prostate cancer stop if no progression is detected?

Prostate 2017 Jun 17;77(9):962-969. Epub 2017 Apr 17.

Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pros.23352DOI Listing
June 2017

Is prostate cancer different in black men? Answers from 3 natural history models.

Cancer 2017 Jun 24;123(12):2312-2319. Epub 2017 Apr 24.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, Washington.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30687DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5459620PMC
June 2017

Estimating the risks and benefits of active surveillance protocols for prostate cancer: a microsimulation study.

BJU Int 2017 04 26;119(4):560-566. Epub 2016 Jun 26.

Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13542DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5859305PMC
April 2017

The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index.

Value Health 2016 Mar-Apr;19(2):153-7. Epub 2016 Jan 14.

Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2015.12.002DOI Listing
August 2016

Mammographic screening in BRCA1 mutation carriers postponed until age 40: Evaluation of benefits, costs and radiation risks using models.

Eur J Cancer 2016 08 15;63:135-42. Epub 2016 Jun 15.

Erasmus University Medical Center, Department of Public Health, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2016.05.012DOI Listing
August 2016

Estimating the individual benefit of immediate treatment or active surveillance for prostate cancer after screen-detection in older (65+) men.

Int J Cancer 2016 May 1;138(10):2522-8. Epub 2016 Feb 1.

Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29976DOI Listing
May 2016

Cost-effectiveness of digital mammography screening before the age of 50 in The Netherlands.

Int J Cancer 2015 Oct 8;137(8):1990-9. Epub 2015 May 8.

Department of Public Health, Erasmus MC, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29572DOI Listing
October 2015

The effects of population-based mammography screening starting between age 40 and 50 in the presence of adjuvant systemic therapy.

Int J Cancer 2015 Jul 13;137(1):165-72. Epub 2014 Dec 13.

Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29364DOI Listing
July 2015

Benefits and harms of mammography screening after age 74 years: model estimates of overdiagnosis.

J Natl Cancer Inst 2015 Jul 6;107(7). Epub 2015 May 6.

Department of Public Health, Erasmus MC, Rotterdam, the Netherlands (NTvR, EAMH, HJdK); Department of Population Medicine, Harvard Medical School/Harvard Pilgrim Health Care Institute, Boston, MA (NKS); Departments of Family and Social Medicine and Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY (CBS); Department of Industrial and Systems Engineering (OA) and Carbone Cancer Center and Department of Population Health Sciences (ATD), University of Wisconsin-Madison, Madison, WI; Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Washington, DC (JSM).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv103DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4822526PMC
July 2015

Response.

J Natl Cancer Inst 2015 Jun 16;107(6):djv111. Epub 2015 Apr 16.

Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands (EH, HdK).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djv111DOI Listing
June 2015

Screening for prostate cancer in the US? Reduce the harms and keep the benefit.

Int J Cancer 2015 Apr 1;136(7):1600-7. Epub 2014 Sep 1.

Department of Public Health, Erasmus Medical Center, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ijc.29136DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452024PMC
April 2015

Predicting the stage shift as a result of breast cancer screening in low- and middle-income countries: a proof of concept.

J Med Screen 2015 Mar 21;22(1):8-19. Epub 2014 Nov 21.

Department for Health Evidence, Radboud university medical center, Nijmegen, The Netherlands Dutch reference centre for screening, Nijmegen, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0969141314559956DOI Listing
March 2015

The influence of disease risk on the optimal time interval between screens for the early detection of cancer: a mathematical approach.

Med Decis Making 2015 02 16;35(2):183-95. Epub 2014 Apr 16.

Department of Public Health, Erasmus MC-University Medical Centre Rotterdam, Rotterdam, the Netherlands (JFO'M, JvR, FWG, EAMH, EWS, JDFH)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0272989X14528380DOI Listing
February 2015

Effects of screening and systemic adjuvant therapy on ER-specific US breast cancer mortality.

J Natl Cancer Inst 2014 Nov 24;106(11). Epub 2014 Sep 24.

Division of Biomedical Informatics Research (DM) and Department of Radiology (DM, SKP), School of Medicine, Stanford University, Stanford, CA (DM); Department of Oncology, Georgetown University Medical Center and Cancer Prevention and Control Program, Georgetown-Lombardi Comprehensive Cancer Center, Washington, DC (AMN, YC, JSM); Department of Public Health, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands (NTvR, HJdK, EAMH); Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute and Harvard Medical School Boston, MA (SJL, HH); Departments of Family and Social Medicine and Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York (CBS); Department of Industrial and Systems Engineering, University of Wisconsin, Madison, WI (OA, MAE); Carbone Cancer Center, University of Wisconsin, Madison, WI (ESB, ATD); University of Texas M.D. Anderson Cancer Center, Houston, TX (DAB, GC); Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, MA (NKS); Department of Surgery, College of Medicine, University of Vermont, VT (BLS).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/dju289DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4271026PMC
November 2014

Nation-wide data on screening performance during the transition to digital mammography: observations in 6 million screens.

Eur J Cancer 2013 Nov 17;49(16):3517-25. Epub 2013 Jul 17.

Erasmus MC, Department of Public Health, Room Na 2318, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2013.06.020DOI Listing
November 2013

Collaborative modeling of the impact of obesity on race-specific breast cancer incidence and mortality.

Breast Cancer Res Treat 2012 Dec 27;136(3):823-35. Epub 2012 Oct 27.

Cancer Prevention and Control Program, Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 3300 Whitehaven Street, Suite 4100, Washington, DC 20007, USA.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-012-2274-3
Publisher Site
http://dx.doi.org/10.1007/s10549-012-2274-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3511695PMC
December 2012

The impact of PLCO control arm contamination on perceived PSA screening efficacy.

Cancer Causes Control 2012 Jun 10;23(6):827-35. Epub 2012 Apr 10.

Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, 1100 Fairview Ave N., Seattle, WA 98109-1024, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10552-012-9951-8DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3556907PMC
June 2012

Interpreting overdiagnosis estimates in population-based mammography screening.

Epidemiol Rev 2011 27;33:111-21. Epub 2011 Jun 27.

Department of Public Health, Erasmus MC, Room AE-137, P.O. Box 2040, 3000 CA Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/epirev/mxr009DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132806PMC
November 2011

Digital mammography screening: weighing reduced mortality against increased overdiagnosis.

Prev Med 2011 Sep 21;53(3):134-40. Epub 2011 Jun 21.

Erasmus MC, Department of Public Health, P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ypmed.2011.06.009DOI Listing
September 2011

More on screening mammography.

N Engl J Med 2011 01;364(3):282-3; author reply 285-6

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1011881DOI Listing
January 2011

Prostate-specific antigen screening in the United States vs in the European Randomized Study of Screening for Prostate Cancer-Rotterdam.

J Natl Cancer Inst 2010 Mar 8;102(5):352-5. Epub 2010 Feb 8.

Department of Public Health, Erasmus Medical Center, PO Box 2040, 3000 CA Rotterdam, the Netherlands.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djp533DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831048PMC
March 2010